Skip to main content
Top
Published in: Tumor Biology 3/2014

01-03-2014 | Research Article

Association of genetic variants of cancer stem cell gene CD44 haplotypes with gallbladder cancer susceptibility in North Indian population

Authors: Kiran Lata Sharma, Anu Yadav, Annapurna Gupta, Sonam Tulsayan, Vijay Kumar, Sanjeev Misra, Ashok Kumar, Balraj Mittal

Published in: Tumor Biology | Issue 3/2014

Login to get access

Abstract

CD44 is an important marker for cancer stem cells. Germline variants in CD44 gene have been associated with susceptibility to breast and nasopharyngeal carcinomas but no study in gallbladder cancer (GBC) has been done yet. The present study included 405 GBC patients and 200 healthy controls from North India. Tagger SNPs for CD44 were selected from the GIH population data. Genotyping was carried out by PCR-RFLP and Taqman probes. Statistical analysis was done by SPSS. Bonferroni correction was applied in subgroup analysis. Logistic regression analysis showed no individual association of CD44 polymorphisms with GBC risk. However, [CCAT] haplotype was associated with overall reduced risk of GBC [P = 0.04, odds ratios (OR) = 0.47]. Gender stratification revealed that [CCAT] and [TAGT] haplotypes were significantly associated with decreased risk in female GBC patients [P = 0.022, OR = 0.38; P = 0.011, OR = 0.17, respectively]. The CAAT haplotype was marginally associated with low GBC risk in patients with co-existing gallstones [P = 0.026, OR = 0.53]. The cancer risk was not further modified with tobacco usage or age of onset. In silico analysis showed change in transcriptional regulation of selected SNPs. This study reports an important role of CD44 haplotypes with reduced risk of GBC.
Appendix
Available only for authorised users
Literature
1.
go back to reference Misra S, Chaturvedi A, Misra NC, Sharma ID. Carcinoma of the gallbladder. Lancet Oncol. 2003;4:167–76.PubMedCrossRef Misra S, Chaturvedi A, Misra NC, Sharma ID. Carcinoma of the gallbladder. Lancet Oncol. 2003;4:167–76.PubMedCrossRef
2.
go back to reference Roa I, Araya JC, Villaseca M, De Aretxabala X, Riedemann P, Endoh K, et al. Preneoplastic lesions and gallbladder cancer: an estimate of the period required for progression. Gastroenterology. 1996;111:232–6.PubMedCrossRef Roa I, Araya JC, Villaseca M, De Aretxabala X, Riedemann P, Endoh K, et al. Preneoplastic lesions and gallbladder cancer: an estimate of the period required for progression. Gastroenterology. 1996;111:232–6.PubMedCrossRef
3.
go back to reference Wistuba II, Gazdar AF. Gallbladder cancer: lessons from a rare tumour. Nat Rev Cancer. 2004;4:695–706.PubMedCrossRef Wistuba II, Gazdar AF. Gallbladder cancer: lessons from a rare tumour. Nat Rev Cancer. 2004;4:695–706.PubMedCrossRef
4.
go back to reference Kozuka S, Tsubone N, Yasui A, Hachisuka K. Relation of adenoma to carcinoma in the gallbladder. Cancer. 1982;50:2226–34.PubMedCrossRef Kozuka S, Tsubone N, Yasui A, Hachisuka K. Relation of adenoma to carcinoma in the gallbladder. Cancer. 1982;50:2226–34.PubMedCrossRef
5.
go back to reference Lazcano-Ponce EC, Miquel JF, Munoz N, Herrero R, Ferrecio C, Wistuba II, et al. Epidemiology and molecular pathology of gallbladder cancer. CA Cancer J Clin. 2001;51:349–64.PubMedCrossRef Lazcano-Ponce EC, Miquel JF, Munoz N, Herrero R, Ferrecio C, Wistuba II, et al. Epidemiology and molecular pathology of gallbladder cancer. CA Cancer J Clin. 2001;51:349–64.PubMedCrossRef
6.
go back to reference Srivastava K, Srivastava A, Sharma KL, Mittal B. Candidate gene studies in gallbladder cancer: a systematic review and meta-analysis. Mutat Res. 2011;728:67–79.PubMedCentralPubMedCrossRef Srivastava K, Srivastava A, Sharma KL, Mittal B. Candidate gene studies in gallbladder cancer: a systematic review and meta-analysis. Mutat Res. 2011;728:67–79.PubMedCentralPubMedCrossRef
7.
go back to reference Lobo NA, Shimono Y, Qian D, Clarke MF. The biology of cancer stem cells. Annu Rev Cell Dev Biol. 2007;23:675–99.PubMedCrossRef Lobo NA, Shimono Y, Qian D, Clarke MF. The biology of cancer stem cells. Annu Rev Cell Dev Biol. 2007;23:675–99.PubMedCrossRef
8.
go back to reference Baumann M, Krause M. Cd44: a cancer stem cell-related biomarker with predictive potential for radiotherapy. Clin Cancer Res. 2010;16:5091–3.PubMedCrossRef Baumann M, Krause M. Cd44: a cancer stem cell-related biomarker with predictive potential for radiotherapy. Clin Cancer Res. 2010;16:5091–3.PubMedCrossRef
9.
go back to reference Shi C, Tian R, Wang M, Wang X, Jiang J, Zhang Z, et al. Cd44+ cd133+ population exhibits cancer stem cell-like characteristics in human gallbladder carcinoma. Cancer Biol Ther. 2010;10:1182–90.PubMedCrossRef Shi C, Tian R, Wang M, Wang X, Jiang J, Zhang Z, et al. Cd44+ cd133+ population exhibits cancer stem cell-like characteristics in human gallbladder carcinoma. Cancer Biol Ther. 2010;10:1182–90.PubMedCrossRef
10.
go back to reference So JY, Lee HJ, Smolarek AK, Paul S, Wang CX, Maehr H, et al. A novel gemini vitamin d analog represses the expression of a stem cell marker cd44 in breast cancer. Mol Pharmacol. 2011;79:360–7.PubMedCentralPubMedCrossRef So JY, Lee HJ, Smolarek AK, Paul S, Wang CX, Maehr H, et al. A novel gemini vitamin d analog represses the expression of a stem cell marker cd44 in breast cancer. Mol Pharmacol. 2011;79:360–7.PubMedCentralPubMedCrossRef
11.
go back to reference Bourguignon LY. Cd44-mediated oncogenic signaling and cytoskeleton activation during mammary tumor progression. J Mammary Gland Biol Neoplasia. 2001;6:287–97.PubMedCrossRef Bourguignon LY. Cd44-mediated oncogenic signaling and cytoskeleton activation during mammary tumor progression. J Mammary Gland Biol Neoplasia. 2001;6:287–97.PubMedCrossRef
12.
go back to reference Bourguignon LY, Singleton PA, Zhu H, Diedrich F. Hyaluronan-mediated cd44 interaction with rhogef and rho kinase promotes grb2-associated binder-1 phosphorylation and phosphatidylinositol 3-kinase signaling leading to cytokine (macrophage-colony stimulating factor) production and breast tumor progression. J Biol Chem. 2003;278:29420–34.PubMedCrossRef Bourguignon LY, Singleton PA, Zhu H, Diedrich F. Hyaluronan-mediated cd44 interaction with rhogef and rho kinase promotes grb2-associated binder-1 phosphorylation and phosphatidylinositol 3-kinase signaling leading to cytokine (macrophage-colony stimulating factor) production and breast tumor progression. J Biol Chem. 2003;278:29420–34.PubMedCrossRef
13.
go back to reference Vazquez A, Grochola LF, Bond EE, Levine AJ, Taubert H, Muller TH, et al. Chemosensitivity profiles identify polymorphisms in the p53 network genes 14-3-3tau and cd44 that affect sarcoma incidence and survival. Cancer Res. 2010;70:172–80.PubMedCrossRef Vazquez A, Grochola LF, Bond EE, Levine AJ, Taubert H, Muller TH, et al. Chemosensitivity profiles identify polymorphisms in the p53 network genes 14-3-3tau and cd44 that affect sarcoma incidence and survival. Cancer Res. 2010;70:172–80.PubMedCrossRef
14.
go back to reference Winder T, Ning Y, Yang D, Zhang W, Power DG, Bohanes P, et al. Germline polymorphisms in genes involved in the cd44 signaling pathway are associated with clinical outcome in localized gastric adenocarcinoma. Int J Cancer. 2011;129:1096–104.PubMedCentralPubMedCrossRef Winder T, Ning Y, Yang D, Zhang W, Power DG, Bohanes P, et al. Germline polymorphisms in genes involved in the cd44 signaling pathway are associated with clinical outcome in localized gastric adenocarcinoma. Int J Cancer. 2011;129:1096–104.PubMedCentralPubMedCrossRef
15.
go back to reference Hiraga T, Ito S, Nakamura H. Cancer stem-like cell marker cd44 promotes bone metastases by enhancing tumorigenicity, cell motility, and hyaluronan production. Cancer Res. 2013;73:4112–22.PubMedCrossRef Hiraga T, Ito S, Nakamura H. Cancer stem-like cell marker cd44 promotes bone metastases by enhancing tumorigenicity, cell motility, and hyaluronan production. Cancer Res. 2013;73:4112–22.PubMedCrossRef
16.
go back to reference Kalekou H, Miliaras D. Immunohistochemical study of microvessel density, cd44 (standard form), p53 protein and c-erbb2 in gallbladder carcinoma. J Gastroenterol Hepatol. 2004;19:812–8.PubMedCrossRef Kalekou H, Miliaras D. Immunohistochemical study of microvessel density, cd44 (standard form), p53 protein and c-erbb2 in gallbladder carcinoma. J Gastroenterol Hepatol. 2004;19:812–8.PubMedCrossRef
17.
go back to reference De Marzo AM, Bradshaw C, Sauvageot J, Epstein JI, Miller GJ. Cd44 and cd44v6 downregulation in clinical prostatic carcinoma: relation to gleason grade and cytoarchitecture. Prostate. 1998;34:162–8.PubMedCrossRef De Marzo AM, Bradshaw C, Sauvageot J, Epstein JI, Miller GJ. Cd44 and cd44v6 downregulation in clinical prostatic carcinoma: relation to gleason grade and cytoarchitecture. Prostate. 1998;34:162–8.PubMedCrossRef
18.
go back to reference Roa I, Villaseca M, Araya J, Roa J, de Aretxabala X, Ibacache G. Garcia M: [cd44 (hcam) expression in subserous gallbladder carcinoma]. Rev Med Chil. 2001;129:727–34.PubMed Roa I, Villaseca M, Araya J, Roa J, de Aretxabala X, Ibacache G. Garcia M: [cd44 (hcam) expression in subserous gallbladder carcinoma]. Rev Med Chil. 2001;129:727–34.PubMed
19.
go back to reference Jiang L, Deng J, Zhu X, Zheng J, You Y, Li N, et al. Cd44 rs13347 c>t polymorphism predicts breast cancer risk and prognosis in Chinese populations. Breast Cancer Res. 2012;14:R105.PubMedCentralPubMedCrossRef Jiang L, Deng J, Zhu X, Zheng J, You Y, Li N, et al. Cd44 rs13347 c>t polymorphism predicts breast cancer risk and prognosis in Chinese populations. Breast Cancer Res. 2012;14:R105.PubMedCentralPubMedCrossRef
20.
go back to reference Xiao M, Hu S, Zhang L, Huang J, Jiang H, Cai X. Polymorphisms of cd44 gene and nasopharyngeal carcinoma susceptibility in a Chinese population. Mutagenesis. 2013;28(5):577–82.PubMedCrossRef Xiao M, Hu S, Zhang L, Huang J, Jiang H, Cai X. Polymorphisms of cd44 gene and nasopharyngeal carcinoma susceptibility in a Chinese population. Mutagenesis. 2013;28(5):577–82.PubMedCrossRef
21.
go back to reference Sharma KL, Misra S, Kumar A, Mittal B. Higher risk of matrix metalloproteinase (mmp-2, 7, 9) and tissue inhibitor of metalloproteinase (timp-2) genetic variants to gallbladder cancer. Liver Int. 2012;32:1278–86.PubMedCrossRef Sharma KL, Misra S, Kumar A, Mittal B. Higher risk of matrix metalloproteinase (mmp-2, 7, 9) and tissue inhibitor of metalloproteinase (timp-2) genetic variants to gallbladder cancer. Liver Int. 2012;32:1278–86.PubMedCrossRef
22.
go back to reference Srivastava A, Sharma KL, Srivastava N, Misra S, Mittal B. Significant role of estrogen and progesterone receptor sequence variants in gallbladder cancer predisposition: a multi-analytical strategy. PLoS One. 2012;7:e40162.PubMedCentralPubMedCrossRef Srivastava A, Sharma KL, Srivastava N, Misra S, Mittal B. Significant role of estrogen and progesterone receptor sequence variants in gallbladder cancer predisposition: a multi-analytical strategy. PLoS One. 2012;7:e40162.PubMedCentralPubMedCrossRef
23.
go back to reference Sharma KL, Misra S, Kumar A, Mittal B. Association of liver X receptors (LXRs) genetic variants to gallbladder cancer susceptibility. Tumour Biol. 2013; In press. Sharma KL, Misra S, Kumar A, Mittal B. Association of liver X receptors (LXRs) genetic variants to gallbladder cancer susceptibility. Tumour Biol. 2013; In press.
25.
go back to reference Gerger A, Zhang W, Yang D, Bohanes P, Ning Y, Winder T, et al. Common cancer stem cell gene variants predict colon cancer recurrence. Clin Cancer Res. 2011;17:6934–43.PubMedCrossRef Gerger A, Zhang W, Yang D, Bohanes P, Ning Y, Winder T, et al. Common cancer stem cell gene variants predict colon cancer recurrence. Clin Cancer Res. 2011;17:6934–43.PubMedCrossRef
26.
go back to reference de Jong MC, Pramana J, van der Wal JE, Lacko M, Peutz-Kootstra CJ, de Jong JM, et al. Cd44 expression predicts local recurrence after radiotherapy in larynx cancer. Clin Cancer Res. 2010;16:5329–38.PubMedCrossRef de Jong MC, Pramana J, van der Wal JE, Lacko M, Peutz-Kootstra CJ, de Jong JM, et al. Cd44 expression predicts local recurrence after radiotherapy in larynx cancer. Clin Cancer Res. 2010;16:5329–38.PubMedCrossRef
27.
go back to reference Tulsyan S, Agarwal G, Lal P, Agrawal S, Mittal RD, Mittal B. Cd44 gene polymorphisms in breast cancer risk and prognosis: a study in north indian population. PLOS ONE. 2013;8:e71073.PubMedCentralPubMedCrossRef Tulsyan S, Agarwal G, Lal P, Agrawal S, Mittal RD, Mittal B. Cd44 gene polymorphisms in breast cancer risk and prognosis: a study in north indian population. PLOS ONE. 2013;8:e71073.PubMedCentralPubMedCrossRef
28.
go back to reference Yanagisawa N, Mikami T, Mitomi H, Saegusa M, Koike M, Okayasu I. Cd44 variant overexpression in gallbladder carcinoma associated with tumor dedifferentiation. Cancer. 2001;91:408–16.PubMedCrossRef Yanagisawa N, Mikami T, Mitomi H, Saegusa M, Koike M, Okayasu I. Cd44 variant overexpression in gallbladder carcinoma associated with tumor dedifferentiation. Cancer. 2001;91:408–16.PubMedCrossRef
29.
go back to reference Yin BB, Wu SJ, Zong HJ, Ma BJ, Cai D. Preliminary screening and identification of stem cell-like sphere clones in a gallbladder cancer cell line gbc-sd. J Zhejiang Univ Sci B. 2011;12:256–63.PubMedCentralPubMedCrossRef Yin BB, Wu SJ, Zong HJ, Ma BJ, Cai D. Preliminary screening and identification of stem cell-like sphere clones in a gallbladder cancer cell line gbc-sd. J Zhejiang Univ Sci B. 2011;12:256–63.PubMedCentralPubMedCrossRef
30.
go back to reference Xing B, Kong YG, Yao Y, Lian W, Wang RZ, Ren ZY. Study on the expression levels of cxcr4, cxcl12, cd44, and cd147 and their potential correlation with invasive behaviors of pituitary adenomas. Biomed Environ Sci. 2013;26:592–8.PubMed Xing B, Kong YG, Yao Y, Lian W, Wang RZ, Ren ZY. Study on the expression levels of cxcr4, cxcl12, cd44, and cd147 and their potential correlation with invasive behaviors of pituitary adenomas. Biomed Environ Sci. 2013;26:592–8.PubMed
31.
go back to reference Herrlich P, Morrison H, Sleeman J, Orian-Rousseau V, Konig H, Weg-Remers S, et al. Cd44 acts both as a growth- and invasiveness-promoting molecule and as a tumor-suppressing cofactor. Ann N Y Acad Sci. 2000;910:106–18. discussion 118–120.PubMedCrossRef Herrlich P, Morrison H, Sleeman J, Orian-Rousseau V, Konig H, Weg-Remers S, et al. Cd44 acts both as a growth- and invasiveness-promoting molecule and as a tumor-suppressing cofactor. Ann N Y Acad Sci. 2000;910:106–18. discussion 118–120.PubMedCrossRef
Metadata
Title
Association of genetic variants of cancer stem cell gene CD44 haplotypes with gallbladder cancer susceptibility in North Indian population
Authors
Kiran Lata Sharma
Anu Yadav
Annapurna Gupta
Sonam Tulsayan
Vijay Kumar
Sanjeev Misra
Ashok Kumar
Balraj Mittal
Publication date
01-03-2014
Publisher
Springer Netherlands
Published in
Tumor Biology / Issue 3/2014
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-013-1340-8

Other articles of this Issue 3/2014

Tumor Biology 3/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine